What you need to know
The MA PMP dataset includes information for the selected categories of controlled substances prescription medications:
Opioid Agonists – Prescription opioids, (referred hereon as ‘Opioids’), are medications that have been used to treat moderate to severe pain in some patients. They contain natural, synthetic, or semi-synthetic chemicals that interact with opioid receptors on nerve cells in the body and brain, and reduce the intensity of pain signals and feelings of pain. MA PMP receives dispensation data on commonly prescribed opioids such as oxycodone, hydrocodone, hydromorphone, oxymorphone, etcetera.
Benzodiazepines – Sometimes called “benzos,” these are sedatives often used to treat anxiety, insomnia, and other conditions. MA PMP receives data on all commonly prescribed benzos. Some examples include alprazolam (Xanax), diazepam (Valium), and clonazepam (Klonopin).
Stimulants – Stimulants are responsible for improving physiological or neurological function. Prescription stimulants are drugs used to treat conditions such as attention deficit hyperactivity disorder (ADHD) or depression. MA PMP receives data on all commonly prescribed stimulants such as Amphetamines, Dextroamphetamines and Methylphenidates.
Opioid Partial Agonists (medications typically prescribed for opioid use disorder) – Treatment for opioid use disorder typically combines the use of medications (methadone, buprenorphine, or naltrexone) with counseling and behavioral therapies. MA PMP receives dispensation data on all partial agonists. However, it does not receive data on partial agonists dispensed as part of Opioid Treatment Programs or Clinics.
Explore PMP Data
MA PMP data can be used for evaluation and research and to provide an important baseline to better inform future policy decisions allowing the state and stakeholders to meaningfully measure whether policy initiatives are effective. Data are available for complete calendar years 2015 to present and is stratified by county.
Prescription Monitoring Program Website - https://www.mass.gov/orgs/prescription-monitoring-program
|Date published:||June 21, 2021|
|Last updated:||June 21, 2021|